Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks

NCT05816538 is registered in ClinicalTrials.gov with University of Rijeka as lead sponsor.

NCT NCT05816538
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05816538 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks
Lead sponsor
University of Rijeka
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 18, 2024
Completion date
December 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, immunologic suppression, levobupivacaine, paravertebral block, pectoralis and serratus plane nerve blocks